Anterix (ATEX) Research & Development (2013 - 2026)

Anterix (ATEX) has reported Research & Development for 14 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 28.0% year-over-year to $1.9 million; the trailing twelve-month figure through Jun 2026 stood at $7.3 million (up 21.12% YoY), and the FY2026 full-year result was $6.9 million, up 12.93% from the prior year.
• Research & Development declined to $1.9 million in Q2 2026 per ATEX's latest filing, from $2.5 million in the prior quarter.
• Across five years, Research & Development topped out at $2.5 million in Q1 2026 and bottomed at $1.2 million in Q1 2022.
• Historically, Research & Development has averaged $1.5 million across 5 years, with a median of $1.4 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Research & Development declined 19.3% in 2025, then surged 72.06% in 2026.
• Over 5 years, Research & Development stood at $1.4 million in 2022, then dropped by 0.36% to $1.4 million in 2023, then decreased by 5.14% to $1.3 million in 2024, then increased by 9.93% to $1.4 million in 2025, then soared by 32.8% to $1.9 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $1.9 million, $2.5 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.